26, 2026: When Novo Nordisk filed suit against Hims & Hers in early February, the case immediately drew attention as a high-stakes patent fight over semaglutide and what it could mean for the broader multi-billion-dollar market for GLP-1 treatments
In another clinical trial , just over 15% of Wegovy users experienced headaches, compared to just over 12% among those taking a placebo
Zepbound: Zepbound is an FDA-approved weight loss medication that contains tirzepatide to help regulate appetite and support weight management
642 Carpenter Avenue Mooresville, NC 28115 (980) 455-0550 Best for patients in: Mooresville, Cornelius, Davidson, Troutman, Statesville, Denver, Sherrills Ford, Mount Mourne, and throughout Iredell County and the Lake Norman area
However, based on the outcomes from earlier studies, several patterns are likely to shape how this drug is prescribed if and when it reaches the market